Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Contemp Clin Trials. 2016 Apr 16;48:99–109. doi: 10.1016/j.cct.2016.04.008

Table 2.

Participant characteristics.

Variable Total sample (N = 250) African American (N = 125) Hispanic (N = 125) p-valuea b
Female, n (%) 201 (80.4) 102 (81.6) 99 (79.2) 0.75025
Age, median (q1, q3) 67 (64, 71) 68 (65, 73) 66 (63, 70) 0.011
Age, categorized, n (%) 0.0076
 60–64 71 (28.4) 28 (22.4) 43 (34.4)
 65–74 141 (56.4) 70 (56.0) 71 (56.8)
 75–88 38 (15.2) 27 (21.6) 11 (8.8)
Education, number of years, median (q1, q3) 9 (5, 12) 12 (11, 14) 5 (2, 7) <0.0001
Education, categorized, n (%) <0.0001
 Less than high school 140 (56.0) 34 (27.2) 106 (84.8)
 High school diploma or equivalent 36 (14.4) 29 (23.2) 7 (5.6)
 Vocational school, some college, associate degree 50 (20.0) 45 (36.0) 5 (4.0)
 College or graduate degree 20 (8.0) 15 (12.0) 5 (4.0)
 Other 4 (1.6) 2 (1.6) 2 (1.6)
Relationship status, n (%) <0.0001
 Single 50 (20.0) 40 (32.0) 10 (8.0)
 Living with spouse/life partner 77 (30.8) 18 (14.4) 59 (47.2)
 Divorced/living separately from spouse/life partner 71 (28.4) 37 (29.6) 34 (27.2)
 Widowed 52 (20.8) 30 (24.0) 22 (17.6)
Average annual income b, n (%) 0.0049
 <10,000 k 98 (39.2) 44 (35.2) 54 (43.2)
 10,000–19,999 k 99 (39.6) 58 (46.4) 41 (32.8)
 >20,000 k 45 (18.0) 23 (18.4) 22 (17.6)
 Unknown/no answer given 8 (3.2) 0 8 (6.4)
Insurance c, n (%) <0.0001
 Medicare only 73 (29.9) 50 (40.0) 23 (19.3)
 Medicaid only 20 (8.2) 10 (8.4) 10 (8.0)
 Medicare plus private 14 (5.7) 8 (6.4) 6 (5.0)
 Medicare plus Medicaid 46 (18.9) 35 (28.0) 11 (9.2)
 No insurance 63 (25.8) 14 (11.2) 49 (41.2)
 Other/private 28 (11.5) 8 (6.4) 20 (16.8)
Employment, n (%) <0.0001
 Full time care-giver 5 (2.0) 1 (0.8) 4 (3.2)
 Part time care-giver 19 (7.6) 9 (7.2) 10 (8.0)
 Retired 134 (53.6) 94 (75.2) 40 (32.0)
 Unemployed/disabled 79 (31.6) 21 (16.8) 58 (46.4)
 Refused/do not know 13 (5.2) 0 (0) 13(10.4)
Psychosocial factors, median (q1, q3)
 BAI d 13 (5, 22) 6 (3, 11) 21 (14, 27) <0.001
 hsCRP (C-reactive protein) 3.2 (1.6, 7.2) 3.9 (2.0, 10.0) 2.6 (1.3, 6.4) 0.0138
 Traumatic stress checklist e 3 (1, 4) 3 (1, 5) 2 (1, 4) 0.0057
 PSE f 2.5 (1, 4) 2 (2, 3) 3 (1, 4) 0.02520
 PTSD g 11 (8, 15) 10 (7, 12) 12 (9, 16.5) <0.0001
 SF-12 h
  SF-12 PCS 25 (24.8, 25.2) 25 (24.8, 25.2) 25 (24.8, 25.2) 0.439
  SF-12 MCS 18.7 (18.3, 19.1) 19.1 (18.8, 19.4) 18.5 (18.1, 18.7) <0.0001
Patient complexity factors
 Total number of medications, median (q1, q3) 5 (3, 7) 5 (3, 7) 5 (3, 6) 0.6306
 Number of chronic conditions including depression symptoms i, n (%) 0.0019
 1 (depression only) 4 (1.6) 3 (2.4) 1 (0.8)
 1–2 (excluding depression) 57 (22.8) 17 (13.6) 40 (32.0)
 3–4 (excluding depression) 127 (50.8) 67 (53.6) 60 (48.0)
 5+ (excluding depression) 62 (24.8) 38 (30.4) 24 (19.2)
a

Wilcoxon used for comparing non-normal data, Chi-square used for categorical data, t-tests used for normally distributed continuous data, Fisher’s exact test used for categorical data with cell counts <5.

b

Total family income before taxes.

c

n = 6 Hispanic participants did not know their insurance status.

d

Beck Anxiety Inventory, response format: 0–3 (not at all to severely-it bothered me a lot), score range: 0–63. Higher score indicates greater anxiety severity.

e

Traumatic Stress Checklist, response format: yes, no, don’t know, refuse, higher score indicated experiencing more stressful events over a lifetime.

f

Past Stressor Events Form, response format: yes, no, refuse, higher score indicates experiencing more stressful events over past year.

g

PCL-Civilian Short Form, response format: range 1–5 (not at all to extremely), score range: 0–30. Higher scores indicate more severe symptoms of PTSD.

h

Short Form Health Survey, includes physical and mental component summary scales. Higher scores indicate worse health status.

i

Chronic conditions include heart attack or myocardial infarction, hypertension, diabetes, cancer, stroke, kidney problems, currently on dialysis, arthritis, lung disease, liver disease, asthma, sleep apnea, neurological disease, obesity (BMI ≥30).